Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 27,046	$ 78,691
Restricted cash	13,770	14,185
Accounts receivable, net	4,759	3,983
Prepaid expenses and other	4,526	9,328
Total current assets	50,101	106,187
Property and equipment, net	622,753	621,199
Other assets, net	2,460	1,166
Total assets	675,314	728,552
Current liabilities:
Accounts payable	10,571	9,168
Accrued expenses	36,619	37,026
Current portion of notes payable, net of deferred financing costs	46,137	69,769
Deferred income	3,576	3,162
Federal and state income taxes payable	176	599
Other current liabilities	732	758
Total current liabilities	97,811	120,482
Notes payable, net of deferred financing costs and current portion	619,798	613,342
Other liabilities	143	288
Total liabilities	717,752	734,112
Commitments and contingencies
Redeemable preferred stock:
Series A convertible preferred stock, $0.01 par value; 41 shares authorized, 41 shares issued and outstanding as of September 30, 2022 and December 31, 2021	42,384	41,250
Shareholders’ equity (deficit):
Preferred stock $0.01 par value per share; 15,000 shares authorized; none issued or outstanding, except Series A convertible preferred stock as noted above	0	0
Common stock $0.01 par value per share; 15,000 shares authorized; 6,670 and 6,634 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively	67	66
Additional paid-in capital	295,595	295,781
Retained deficit	(380,484)	(342,657)
Total shareholders’ equity (deficit)	(84,822)	(46,810)
Total liabilities, redeemable preferred stock and shareholders’ equity (deficit)	$ 675,314	$ 728,552